Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 251-073-2 | CAS number: 32509-66-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 Nov - 7 Dec 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline conform GLP study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL - 5960 AD Horst/The Netherlands
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 19.6 +/- 0.9 g
- Housing: single in Macrolon Type I cages with wire mesh top with granulated soft wood bedding
- Diet (e.g. ad libitum): pelleted standard diet (Harlan Winkelmann GmbH, Borchen, Germany), ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 5 days prior to the start of dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30-70 %
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 1 Dec To: 7 Dec 2004 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 7.5, 15, 30%
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
To determine the highest non-irritant and technically applicable test item concentration, a pre-test was performed in two mice with concnetrations of 5.0, 10.0, 20.0 and 30.0% (w/v) dissolved in acetone:olive oil, 4:1 (v/v). The preparations were made freshly before each dosing occasion. The top dose is the highest technically achievable concentration whilst avoiding systemic toxicity and excessive local irritation.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA)
- Criteria used to consider a positive response: The sensitivity and reliability of the experimental technique employed was assessed by use of a
substance which is known to have skin sensitisation properties in CBA/CaOlaHsd mice (α-Hexylcinnamaldehyde in acetone:olive oil, 4:1 )
TREATMENT PREPARATION AND ADMINISTRATION:
25 µl was spread to the entire dorsal surface of each ear of each mouse once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the the relevant vehicle alone (control animals). On day 6 an injection of 250 µl phosphate buffered saline (PBS) containing 19.6 µCi of 3H-methyl thymidine (3H-TdR) was made into the tail vein of each experimental mouse. Five hours later, the draining Auricular lymph node of each ear was excised and pooled per group (8 nodes per group) into PBS. A single cell suspension of lymph node cells was prepared from each group. After washing two times with phosphate buffered saline the lymph node cells were resuspended in 5 % trichloroacetic acid and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid and transferred to plastic scintillation vials. The level of 3HTdR incorporation was then measured on a ß-scintillation counter. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated for the body weights.
A statistical analysis was conducted for assessment of the dose response relationship, and the EC3 value was calculated according to the equation
EC3 = (a-c) [(3-d)/(b-d)] + c
where EC3 is the estimated concentration of the test item requird to produce a 3-fold increase in draining lymph node cell proliferative activity (a, b) and (c, d) are respectively the co-ordinates of the two pair of data lying immediately above and below the S.I. value of 3 on the local lymph node assay dose response plot. - Positive control results:
- The sensitivity and reliability of the experimental technique employed was assessed by use of Hexylcinnaldehyde which is known to have skin sensitisation properties in CBA/CaOlaHsd mice.
The EC3 value was calculated to be 9.9%. - Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- CG1 /test item concentration: 0 % (w/w); 4 animals
- Key result
- Parameter:
- SI
- Value:
- 0.75
- Test group / Remarks:
- TG 2 / test item concentration 7.5 % (w/w); 4 animals
- Remarks on result:
- other:
- Remarks:
- The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
- Key result
- Parameter:
- SI
- Value:
- 0.73
- Test group / Remarks:
- TG 3/test item concentration 15 % (w/w); 4 animals
- Remarks on result:
- other:
- Remarks:
- The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
- Key result
- Parameter:
- SI
- Value:
- 1.07
- Test group / Remarks:
- TG 4/test item concetration 30 % (w/w); 4 animals
- Remarks on result:
- other:
- Remarks:
- The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test itemHostanox O 3 was found to be not a skin sensitiser under the described conditions.
- Executive summary:
The sensitization potential was investigated according to OECD Guideline 429.
The test item concentrations choosen for the LLNA test were 7.5, 15.0 and 30.0 %.
No deaths occurred during the study period. The animals treated with 7.5 and 15 % of the test itemdid not show any clinical signs during the course of the study. At the highest dose of 30 % the ear skin of all four animals was swollen and inflamed after the second and third application.
In this study Stimulation Indices of 0.75, 0.73 and 1.07 were determined with the test item at concentrations of 7.5, 15.0 and 30.0 % (w/v) in Acetone:Olive oil, 4:1 (v/v). Hostanox O 3 was found to be not a skin sensitiser.
Reference
Table 1: Calculation and Results of Individual Data
Vehicle: acetone:olive oil (4+1 v/v)
Test item concentration % (w/w) |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
4.8 |
--- |
--- |
--- |
--- |
--- |
BG II |
0.0 |
--- |
--- |
--- |
--- |
0 |
CG 1 |
8271.0 |
8268.6 |
8 |
1033.6 |
1.00 |
7.5 |
TG 2 |
6212.9 |
6210.5 |
8 |
776.3 |
0.75 |
15.0 |
TG 3 |
6037.2 |
6034.8 |
8 |
754.4 |
0.73 |
30.0 |
TG 4 |
8879.9 |
8877.5 |
8 |
1109.7 |
1.07 |
BG = Background (1 ml 5% trichloroacetic acid) in duplicate
CG 1 = Control Group
TG 2-4= Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled
The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
No deaths occurred during the study period. The animals treated with 7.5 and 15 % of the test itemdid not show any clinical signs during the course of the study. At the highest dose of 30 % the ear skin of all four animals was swollen and inflamed after the second and third application.
Migrated from Short description of key information:
The sensitization potential of Ethylene-bis[3,3-bis(3-tert.-butyl-4-hydroxyphenyl)butyrate] was investigated according to OECD Guideline 429. The test item concentrations chosen for the LLNA test were 7.5, 15, 30 %.
Justification for selection of skin sensitisation endpoint:
Guideline conform GLP study.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Ethylene-bis[3,3-bis(3-tert.-butyl-4-hydroxyphenyl)butyrate] did not show skin sensitizing properties in the Local Lymph Node Assay according to the current OECD guidelines. Allergic skin reactions or case reports of acute contact dermatitis to Ethylene-bis[3,3-bis(3-tert.-butyl-4-hydroxyphenyl)butyrate] have not been described in the literature. Therefore, the substance does not have to be classified as a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.